Thalidomide News and Research

RSS
Thalidomide is a drug that is used to treat multiple myeloma in patients who have just been diagnosed, and a painful skin disease related to leprosy. It is also being studied in the treatment of other types of cancer. Thalidomide belongs to the family of drugs called angiogenesis inhibitors. Also called Thalomid.
Cancer drug could be used to treat brain aneurysms, shows research

Cancer drug could be used to treat brain aneurysms, shows research

Researchers develop novel mouse model to study immunomodulatory therapies

Researchers develop novel mouse model to study immunomodulatory therapies

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Purdue researchers develop new chemical process to find better drug 'fits' for patients

Purdue researchers develop new chemical process to find better drug 'fits' for patients

Scientists solve 60-year-old mystery of how thalidomide caused birth defects

Scientists solve 60-year-old mystery of how thalidomide caused birth defects

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Legacy of social and political factors may be responsible for vaccine hesitancy

Legacy of social and political factors may be responsible for vaccine hesitancy

Desymmetrization paves way for new bioactive compounds

Desymmetrization paves way for new bioactive compounds

Valproic acid exposure results in characteristics linked to autism, zebrafish study shows

Valproic acid exposure results in characteristics linked to autism, zebrafish study shows

New tool developed to assess likely risk of drug turning into potentially harmful version

New tool developed to assess likely risk of drug turning into potentially harmful version

New study uncovers 13 previously-unknown genetic risk variants for restless legs syndrome

New study uncovers 13 previously-unknown genetic risk variants for restless legs syndrome

Childhood obesity starts in the womb?

Childhood obesity starts in the womb?

Additions to standard therapy do not improve progression-free survival in patients with multiple myeloma

Additions to standard therapy do not improve progression-free survival in patients with multiple myeloma

Chemists find efficient way to convert organic molecules into new medicines

Chemists find efficient way to convert organic molecules into new medicines

Mutations in STN1 gene cause Coats plus syndrome

Mutations in STN1 gene cause Coats plus syndrome